SMARCA2 and breast carcinoma: These data suggest that both BRG1 and BRM are necessary to promote breast cancer cell proliferation in triple-negative breast cancer cell lines, and knockdown of both ATPases can precisely reduce cell proliferation by decreasing the rate of cell cycle progression [63].